Skip to main content

Table 1 Overall characteristic of ASO patients and healthy donors included in study

From: MicroRNA profile of circulating CD4+ T cells in aged patients with atherosclerosis obliterans

Variable

ASO group

Healthy group

P value

Gender

   

 Male

26

16

P > 0.05

 Female

7

7

Age (years old)

   

 35–55

3

13

P < 0.05

 56–75

21

8

 76–95

9

3

Fontaine classification

   

 I

0

0

 

 II

10

0

 

 III

7

0

 

 IV

16

0

 

Surgery

0

0

 

Smoking

10

0

P < 0.01

Hepatic Lipidosis

11

0

 

Hypertension

18

0

P < 0.01

Hyperlipidemia

0

0

 

Diabetes

3

0

P > 0.05

Renal diseases

0

0

 

Autoimmune diseases

0

0

 

Infective diseases

0

0

 

Immunosuppressive treatment

0

0

 

Lipid-lowering agents

0

0

 

Tumors

0

0

 

Retinal arteriosclerosis

33

0

 

FMD

   

 < 10%

33

0

 

 ≥ 10%, ≤ 20%

0

24

 

Blood glucose (mmol/L)

   

 ≤ 6.0

33

24

P > 0.05

 > 6.0

0

0

WBC (× 109)

   

 ≤ 4.0

0

0

P > 0.05

 > 4.0, ≤ 10.0

33

24

 > 10.0

0

0

Lymphocytes (× 109)

   

  ≤ 1.0

0

0

P < 0.05

 > 1.0, ≤ 3.3

33

24

 > 3.3

0

0

  1. ASO: atherosclerosis obliterans; FMD: Flow-mediated vasodilation; WBC: White blood cells